Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Editorial: Comparative Effectiveness in Chronic Constipation-Interpreting Real-World Evidence. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: July 26, 2026
Biomarkers in Irritable Bowel Syndrome: Bridging Gut-Brain Mechanisms to Precision Care.
Journal: Current gastroenterology reports
Published: June 01, 2026
Editorial: Upadacitinib in Perianal Crohn's Disease.
Journal: Alimentary pharmacology & therapeutics
Published: May 11, 2026
Elobixibat Versus Prucalopride in Functional Constipation: A Prospective Comparative Effectiveness Study.
Journal: Alimentary pharmacology & therapeutics
Published: April 28, 2026
Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease: A Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: April 20, 2026
Beyond the binary: understanding inflammatory bowel disease in the context of HIV-induced immunodeficiency.
Journal: Expert review of clinical immunology
Published: March 06, 2026
Liver stiffness at baseline as a marker of hepatocellular carcinoma in cirrhosis: A matched analysis.
Journal: World journal of gastrointestinal pathophysiology
Published: March 03, 2026
Hepatic Outcomes in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease: Propensity-Matched Cohort Study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 15, 2026
Acute myeloid leukemia and gut microbiome: bidirectional effects and opportunities for intervention.
Acute myeloid leukemia and gut microbiome: bidirectional effects and opportunities for intervention.
Journal: Annals of hematology
Published: January 10, 2026
Evolving prokinetic therapy: New targets and therapeutic opportunities in gastrointestinal motility disorders.
Journal: World journal of gastrointestinal pharmacology and therapeutics
Published: January 07, 2026
Review Article: TL1A Inhibitors in IBD - Mechanistic Rationale and Clinical Evidence.
Journal: Alimentary pharmacology & therapeutics
Published: January 05, 2026
Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction-associated steatotic liver disease.
Journal: Frontiers in epidemiology
Published: January 02, 2026
Last Updated: 09/26/2026